$869 Thousand is the total value of Vivo Capital, LLC's 48 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 17.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HRMY | Sell | Harmony Biosciences Holdings Inc | $143,604 | -99.9% | 2,606,247 | -23.4% | 16.53% | -0.6% |
| TERN | Buy | Terns Pharmaceuticals Inc | $67,778 | -99.8% | 6,657,992 | +12.9% | 7.80% | +103.4% |
| VRDN | Buy | Viridian Therapeutics Inc | $49,020 | -99.9% | 1,678,207 | +1.1% | 5.64% | +50.1% |
| ALXO | ALX Oncology Holdings Inc | $47,560 | -99.9% | 4,220,048 | 0.0% | 5.48% | +22.8% | |
| GERN | Buy | Geron Corp | $46,664 | -99.9% | 19,282,834 | +26.5% | 5.37% | +36.5% |
| IMPL | Impel NeuroPharma Inc | $43,272 | -99.7% | 2,884,789 | 0.0% | 4.98% | +221.2% | |
| Sell | Ventyx Biosciences Inc | $42,735 | -99.9% | 1,303,294 | -3.9% | 4.92% | -5.9% | |
| SVA | Sinovac Biotech Ltd. | $38,173 | -99.9% | 5,900,000 | 0.0% | 4.40% | +4.3% | |
| ALLK | Allakos Inc | $34,692 | -99.9% | 4,120,134 | 0.0% | 3.99% | +43.5% | |
| TARS | Tarsus Pharmaceuticals Inc | $33,164 | -99.9% | 2,262,200 | 0.0% | 3.82% | -10.7% | |
| PCVX | Buy | Vaxcyte Inc | $27,787 | -99.7% | 579,508 | +43.3% | 3.20% | +198.4% |
| Buy | Astria Therapeutics Inc | $25,033 | -99.7% | 1,681,199 | +68.1% | 2.88% | +188.8% | |
| COGT | Buy | Cogent Biosciences Inc | $23,062 | -99.9% | 1,994,941 | +5.9% | 2.66% | -14.4% |
| KDNY | Chinook Therapeutics Inc | $22,850 | -99.9% | 872,151 | 0.0% | 2.63% | +39.0% | |
| VECT | New | VectivBio Holding AG | $20,218 | – | 2,333,300 | +100.0% | 2.33% | – |
| AVDL | Sell | Avadel Pharmaceuticals PLCadr | $19,719 | -99.9% | 2,754,095 | -6.2% | 2.27% | +39.7% |
| CMPX | Buy | Compass Therapeutics Inc | $17,895 | -99.6% | 3,557,630 | +77.9% | 2.06% | +309.5% |
| ACRS | Aclaris Therapeutics, Inc. | $14,153 | -99.9% | 898,631 | 0.0% | 1.63% | +4.4% | |
| LEGN | Legend Biotech Corp Sponsoredsponsored ads | $12,199 | -99.9% | 244,375 | 0.0% | 1.40% | +27.6% | |
| AMRS | Amyris, Inc | $11,859 | -99.9% | 7,750,828 | 0.0% | 1.36% | -45.4% | |
| ZLAB | Buy | Zai Lab Ltd ADRadr | $10,399 | -99.9% | 338,721 | +24.7% | 1.20% | +16.8% |
| GTH | Genetron Holdings Ltdads | $9,099 | -99.9% | 8,124,174 | 0.0% | 1.05% | +49.5% | |
| BLU | Bellus Health Inc | $8,361 | -99.9% | 1,017,152 | 0.0% | 0.96% | -18.8% | |
| TIL | Instil Bio Inc | $7,867 | -100.0% | 12,486,787 | 0.0% | 0.91% | -86.4% | |
| VERA | Sell | Vera Therapeutics Inc | $7,753 | -99.9% | 400,666 | -39.9% | 0.89% | -43.0% |
| IO Biotech Inc | $6,936 | -99.9% | 3,015,545 | 0.0% | 0.80% | -11.4% | ||
| MRUS | Sell | Merus NV | $6,785 | -99.9% | 438,590 | -0.8% | 0.78% | -20.1% |
| DYN | Dyne Therapeutics Inc | $6,695 | -99.9% | 577,642 | 0.0% | 0.77% | -4.8% | |
| Aadi Bioscience Inc | $6,538 | -99.9% | 509,572 | 0.0% | 0.75% | -5.3% | ||
| KALV | Sell | KalVista Pharmaceuticals Inc. | $5,787 | -100.0% | 856,008 | -44.2% | 0.67% | -72.9% |
| ARWR | Arrowhead Pharmaceuticals Inc | $5,573 | -99.9% | 137,411 | 0.0% | 0.64% | +28.1% | |
| BCAB | New | BioAtla Inc | $5,257 | – | 637,181 | +100.0% | 0.60% | – |
| Buy | Cincor Pharma Inc | $5,182 | -100.0% | 421,635 | +20.7% | 0.60% | -52.8% | |
| BOLT | Bolt Therapeutics Inc | $5,033 | -99.9% | 3,871,291 | 0.0% | 0.58% | -8.5% | |
| IOVA | Iovance Biotherapeutics Inc | $4,186 | -99.9% | 655,057 | 0.0% | 0.48% | -30.4% | |
| DBVT | DBV Technologies SAsponsored adr | $4,145 | -99.9% | 2,708,875 | 0.0% | 0.48% | -9.8% | |
| OLMA | Olema Pharmaceuticals Inc | $4,139 | -99.9% | 1,689,515 | 0.0% | 0.48% | -7.4% | |
| VRNA | Verona Pharma PLCads | $3,637 | -100.0% | 4,249,918 | 0.0% | 0.42% | -91.3% | |
| ALGS | Aligos Therapeutics Inc | $3,380 | -99.9% | 3,547,030 | 0.0% | 0.39% | -9.7% | |
| Sera Prognostics Inc | $2,339 | -99.9% | 1,856,011 | 0.0% | 0.27% | -18.0% | ||
| GRCL | Sell | Gracell Biotechnologies Incsponsored ads | $2,211 | -99.9% | 961,358 | -0.0% | 0.26% | -25.4% |
| CDXS | Codexis, Inc | $1,809 | -99.9% | 388,144 | 0.0% | 0.21% | -20.0% | |
| ASLN | Aslan Pharmaceuticals Ltdads | $1,023 | -99.9% | 2,840,909 | 0.0% | 0.12% | -37.2% | |
| RZLT | Rezolute Inc | $1,013 | -99.9% | 489,473 | 0.0% | 0.12% | -20.9% | |
| IMUX | New | Immunic Inc | $833 | – | 632,184 | +100.0% | 0.10% | – |
| Minerva Surgical Inc | $495 | -100.0% | 2,215,667 | 0.0% | 0.06% | -70.8% | ||
| FIXX | Homology Medicines, Inc. | $466 | -99.9% | 370,068 | 0.0% | 0.05% | -18.2% | |
| DTIL | Precision Biosciences Inc | $167 | -99.9% | 140,255 | 0.0% | 0.02% | -5.0% | |
| MTCR | Exit | Metacrine Inc | $0 | – | -146,426 | -100.0% | -0.01% | – |
| CLDX | Exit | Celldex Therapeutics Inc | $0 | – | -198,983 | -100.0% | -0.62% | – |
| STSA | Exit | Satsuma Pharmaceuticals Inc | $0 | – | -1,232,394 | -100.0% | -0.82% | – |
| ISEE | Exit | Iveric Bio Inc | $0 | – | -483,413 | -100.0% | -0.96% | – |
| ASND | Exit | Ascendis Pharma A/Ssponsored adr | $0 | – | -146,025 | -100.0% | -1.66% | – |
| RLMD | Exit | Relmada Therapeutics Inc | $0 | – | -713,238 | -100.0% | -2.92% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 29 | Q3 2023 | 33.5% |
| CODEXIS INC | 29 | Q3 2023 | 8.0% |
| ASCENDIS PHARMA A/S | 25 | Q3 2022 | 24.0% |
| KALVISTA PHARMACEUTICALS INC | 25 | Q3 2023 | 3.9% |
| Verona Pharma PLC ADR | 24 | Q3 2023 | 7.6% |
| AMYRIS INC | 23 | Q3 2023 | 8.8% |
| EIGER BIOPHARMACEUTICALS INC | 23 | Q1 2022 | 8.7% |
| Zai Lab Ltd ADR | 22 | Q3 2023 | 1.8% |
| Arrowhead Pharmaceuticals Inc | 21 | Q3 2023 | 6.9% |
| HOMOLOGY MEDICINES INC | 21 | Q3 2023 | 3.7% |
View Vivo Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SINOVAC BIOTECH LTDSold out | August 27, 2018 | 0 | 0.0% |
View Vivo Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-22 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Vivo Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.